Monitoring of Antibiotic in Children used for Acute Respiratory tract Infection
Corresponding Author(s) : Dr. Rajesh Asija
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 9 No. 1 (2021): 2021 Volume - 9 Issue-1
Abstract
Respiratory tract infections are among the most frequently encountered clinical conditions and are one of the most common reasons for pediatric consultations in primary healthcare. The aim of the present study was to study the prescribing pattern of antibiotics in children with acute respiratory tract infections
Methods
A prospective observational study was conducted in pediatric department in a tertiary care teaching hospital for a period of 6 months. All the patients who were prescribed with any of antibiotic drug therapy were included in the study and reviewed.
Results
Among the 78 patients recruited for the study, 35 children were diagnosed with bronchopneumonia. In our study, 98.71% were prescribed with antibiotics; out of which, the most commonly prescribed antibiotics were i.v. cefotaxime (39.7%) and i.v. ceftriaxone (39.7%). The most commonly prescribed antibiotic in bronchitis, URTI, bronchiolitis plus aspiration pneumonia was cefotaxime. In bronchiolitis and bronchopneumonia, the commonly prescribed antibiotic was ceftriaxone.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
References
[2]. Schaad UB. Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85. Eur Respir Rev., 14, 2015, 74–77.
[3]. Paul S, O’Callaghan C, McKee N. Effective management of lower respiratory tract infections in childhood. Nurs Child Young People, 23, 2017, 27–34.
[4]. Gill D, O’Brien N, editors. Paediatric Clinical Examination Made Easy. London, UK: Churchill Livingston, 12, 2017.
[5]. Asscher A.W, Parr G.D, Whitmarsh V.B. Towards the safer use of medicines BMJ 1995, 1003-05
[6]. Gidal BE, Garnett WR, Graves N. Pharmacotherapy- A Pathophysiologic Approach- 5th edition The McGraw Hill Companies Inc, 5, 2002, 1031- 59.
[7]. Clark JE, Hammal D, Hampton F, Spencer D, Parker L. Epidemiology of community-acquired pneumonia in children seen in hospital. Epidemiol Infect. 135, 2017, 262–269.
[8]. Thomson A, Harris M. Community-acquired pneumonia in children: what’s new? Thorax, 66, 2015, 927–928.
[9]. Dosh SA, Hickner JM, Masnous AG, Ebell MH. Predictors of antibiotic prescribing for non-specific upper respiratory infections. J Fam Pract, 49, 2000, 407-14.
[10]. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 365, 2015, 579–587.